Health ❯Healthcare ❯Pharmaceuticals ❯Drug Approval
Clinical Trials Weight Management Patient Care Diabetes Pharmaceuticals
Phase 3 data recorded an average 7.9% weight loss alongside blood sugar reductions up to 1.6% with side effects akin to injectables.
